Company Filing History:
Years Active: 2019
Title: The Innovative Contributions of Marcus Schmidt
Introduction
Marcus Schmidt is a notable inventor based in Mainz-Kastel, Germany. He has made significant contributions to the field of medical science, particularly in cancer treatment. His work focuses on improving chemotherapy regimens for patients suffering from breast cancer.
Latest Patents
Marcus Schmidt holds a patent for a method that predicts the benefit of including taxane in chemotherapy for breast cancer patients. This innovative method involves determining the expression levels of the marker genes S100P and PCSK6. By mathematically combining these expression level values, a combined score is generated. This score is then compared to a reference value, where a high score indicates a potential benefit from taxane inclusion, while a low score suggests otherwise.
Career Highlights
Marcus Schmidt is associated with Sividon Diagnostics GmbH, where he applies his expertise in developing predictive methods for cancer treatment. His work has the potential to enhance patient outcomes and tailor chemotherapy regimens more effectively.
Collaborations
Some of his notable coworkers include Jan Brase and Ralf Kronenwett, who contribute to the innovative environment at Sividon Diagnostics GmbH.
Conclusion
Marcus Schmidt's contributions to cancer treatment through his patented methods exemplify the impact of innovation in medical science. His work continues to pave the way for improved patient care and treatment strategies.